Learn about LipiGesic-M
LipiGesic-M is an ideal first-line therapy for migraine pain and associated symptoms. It has superior efficacy and an excellent safety profile with no known drug interactions. Each patent-pending dose is individually packed for sublingual delivery so there’s no measuring or mess. And, it’s less expensive than prescription medication which cuts treatment costs dramatically.
Read More
Investor Information
PuraMed uses a unique sublingual (under the tongue) delivery system utilizing the capillary structure under the tongue which is very close to the surface allowing for fast absorption and action. Sublingual delivery is also able to bypass the liver and digestive system which allows for smaller dosage requirements. PuraMed BioScience, Inc. emphasizes science as the key to success. For this reason, the Company believes its products will outperform other drugs currently available in the U.S.
Read More
Contact a Representative
Would you like to speak to a PuraMed representative?
Phone: 715-359-6373
Read more to locate the right representative for you.
Order a Sample
Are you a retailer or wholesaler?
We supply literature, pricing, specifications, and samples to approved retailers and wholesalers. Submit your information for approval to receive a sample here.
Company News
SCHOFIELD, Wis., April 24, 2012 /PRNewswire/ – PuraMed BioScience, Inc. ® (OTC Bulletin Board: PMBS), the producer of over-the-counter medicinal and healthcare products, has implemented ...
“When you patrol the micro-cap market niche you will every so often feel a thrill if you think you have found a fabulous winner early,” ...
SCHOFIELD, Wis., Feb.15, 2012 /PRNewswire/ – PuraMed BioScience®, Inc. (OTC Bulletin Board: PMBS), the producer of over-the-counter medicinal and healthcare products, announced today its financial results ...
